share_log

Stifel Maintains Buy on Disc Medicine, Raises Price Target to $73

Moomoo 24/7 ·  Apr 8 08:44

Stifel analyst Benjamin Burnett maintains Disc Medicine (NASDAQ:IRON) with a Buy and raises the price target from $71 to $73.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment